NPCE Stock Analysis: Buy, Sell, or Hold?
NPCE - Neuropace, Inc. Common Stock
$15.76
0.39 (2.50%)
▲
5d:
+2.5%
30d:
-3.22%
90d:
+17.75%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When NPCE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NPCE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NPCE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NPCE is currently trading at $15.76, which is considered fair relative to its 30-day fair value range of $15.42 to $16.59.
Technical Outlook: Technically, NPCE is in a uptrend. Immediate support is located at $14.88, while resistance sits at $16.43.
Market Sentiment: NPCE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $20.00 (+30.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NPCE is in a uptrend. Immediate support is located at $14.88, while resistance sits at $16.43.
Market Sentiment: NPCE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $20.00 (+30.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$15.42 -
$16.59
Company Quality Score
52/100
(HOLD)
Options IV Signal
54th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
54.2%
Protect Your Profits
Holding NPCE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 54th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.1% below Wall St target ($20.00)
Trading Range Analysis
30-Day Trading Range
$15.42 -
$16.59
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$2.16
(13.7%)
Support & Resistance Levels
Support Level
$14.88
Resistance Level
$16.43
Current Trend
Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-51.70
Wall Street Target
$20.00
(+30.1%)
Revenue Growth (YoY)
-2.0%
Profit Margin
-21.7%
Share & Embed Analysis
Last updated: June 23, 2026 10:49 AM ET
Data refreshes hourly during market hours. Next update: 11:49 AM
Data refreshes hourly during market hours. Next update: 11:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NPCE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 57 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 61 BUY |
Advanced NPCE Option Strategies
Professional options setups generated by AI based on today's NPCE price and gamma walls.
